Innophos Reaches New 52-Week High (IPHS)

NEW YORK ( TheStreet) -- Innophos Holdings (Nasdaq: IPHS) hit a new 52-week high Friday as it is currently trading at $49.93, above its previous 52-week high of $49.89 with 84,933 shares traded as of 2:17 p.m. ET. Average volume has been 144,000 shares over the past 30 days.

Innophos has a market cap of $1.1 billion and is part of the basic materials sector and chemicals industry. Shares are up 35.3% year to date as of the close of trading on Thursday.

Innophos Holdings, Inc., together with its subsidiaries, produces and sells specialty phosphates primarily in North America. The company has a P/E ratio of 18, equal to the average chemicals industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
  • Practice your IPHS trading strategies and win cash in our stock game.

TheStreet Ratings rates Innophos as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Innophos Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing